Cargando…
Prevalence of and Risk Factors for Levofloxacin-Resistant E. coli Isolated from Outpatients with Urinary Tract Infection
PURPOSE: Levofloxacin has been widely used because of its broad spectrum and excellent penetration of the prostate. But levofloxacin-resistant Escherichia coli (E.coli) has been reported all over the world. We analyzed the annual levofloxacin resistance of E. coli and its risk factors. MATERIALS AND...
Autores principales: | Jang, Woo Hyuk, Yoo, Dong Hoon, Park, Seong Woon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Urological Association
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3162222/ https://www.ncbi.nlm.nih.gov/pubmed/21927703 http://dx.doi.org/10.4111/kju.2011.52.8.554 |
Ejemplares similares
-
Levofloxacin in the treatment of complicated urinary tract infections and acute pyelonephritis
por: McGregor, Jessina C, et al.
Publicado: (2008) -
Outcomes of high-dose levofloxacin therapy remain bound to the levofloxacin minimum inhibitory concentration in complicated urinary tract infections
por: Armstrong, Eliana S., et al.
Publicado: (2016) -
Antibiotic resistance in children with E coli urinary tract infection
por: Russell, Grant
Publicado: (2016) -
1450. Risk Factors for Antibiotic Resistance of Escherichia coli Urinary Isolates in Outpatients
por: Frisbie, Lauren, et al.
Publicado: (2019) -
Levofloxacin Versus Ciprofloxacin in the Treatment of Urinary Tract Infections: Evidence-Based Analysis
por: Cao, Dehong, et al.
Publicado: (2021)